Dr. Pankaj Goyal

About

Dr Pankaj Goyal has been working in the field of Medical Oncology for past 6 years at RGCI & RC,Delhi and has more than 18 years of experience in field of medicine. He has rich experience in management of both hematological & non hematological malignancies (breast, lung and other solid tumors). He has also cleared “European Certified Medical Oncologist” exam conducted by ESMO Medical Oncology.

Dr. Pankaj has keen interest in clinical research & research ethics. He is an active member of a number of professional bodies & societies including European Society for Medical Oncology (ESMO). He has done many oral and poster presentations in national and international conferences. He also has a keen interest in the importance of excellent communication skills on the quality and outcomes of patients. His expertise spans in all types of chemotherapy, intensive protocols, immunotherapy, hormonal therapy in addition to dealing with oncological emergencies, including medical care of patients. He holds deep interest in breast cancer, lung cancer, gastro – intestinal cancer, gyanecological cancer and lymphoma / leukemia / myeloma. He was also awarded the best physician in 2015 at RGCI & RC.

PROFESSIONAL JOURNEY

Awards

• Best Resident Doctor in Rajiv Gandhi Cancer Hospital in 2014.

Publications:

• Efficacy and Toxicity Profile of Maintenance Pemetrexed in Patients with Stage IV adenocarcinoma Lung in Indian Population. Pankaj et al.  South Asian J Cancer 5 (4), 196-203.  Oct-Dec 2016.
• Upadhyay A, Goel V, Batra U, Goyal P, Dutta K, Aggarwal M, Doval D C. Two cases of ovarian carcinoma with endobronchial metastases: Rare presentation. South Asian J Cancer 2015; 4:149.
• Chandragouda D, Doval DC, Mahanta A, Goel V, Upadhyay A, Goyal P, et al. FOLFOX-4 as second-line therapy after failure of gemcitabine and platinum combination in advanced gall bladder cancer patients. Japanese Journal of Clinical Oncology, 2015, 1-6.
• Talwar V, Raina S, Goel V, Doval D. Gemcitabine and Carboplatin in Inoperable, LocoRegionally Advanced and Metastatic Gallbladder Cancer- A Study from Northern Indian Cancer Institute. British Journal of Medicine & Medical Research, 19(12): 1-7, 2017.
• Pemetrexed maintenance in NSCLC -- Poster Presentation  at the  12th  International Conference of Asian Clinical Oncology Society (ACOS)  April, 2016, New Delhi.
• To Assess Efficacy of First Line TKIs in EGFR Mutant Advanced NSCLC Patients from North India: Journal of Thoracic Oncology, 2016.
• Epidemiology and resistance pattern of bacterial isolates among cancer patients in a tertiary care oncology centre in North India. Indian Journal of Cancer 2016.
• Poster presentation in ESMO Singapore "efficacy and safety profile of Eribulin Mesylate in advanced breast cancer.
• Paper presentation in RGCON 2017 awarded second best: Role of ki-67 index in breast cancer.
• Review article "circulatory tumor cells in breast cancer" International journal of molecular and immune-oncology 2017.
• Dash P, Goel V, Talwar V, Doval DC, Raina S, Goyal P, Upadhyay A, Patnaik N. Study of efficacy and safety of modified adjuvant intraperitoneal chemotherapy regimen in carcinoma ovary. Indian J Cancer. 2016 Oct-Dec; 53(4):607-611.